Maria Bjerke

10.7k total citations · 1 hit paper
79 papers, 4.2k citations indexed

About

Maria Bjerke is a scholar working on Psychiatry and Mental health, Physiology and Molecular Biology. According to data from OpenAlex, Maria Bjerke has authored 79 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Psychiatry and Mental health, 43 papers in Physiology and 21 papers in Molecular Biology. Recurrent topics in Maria Bjerke's work include Alzheimer's disease research and treatments (42 papers), Dementia and Cognitive Impairment Research (41 papers) and Neurological Disease Mechanisms and Treatments (11 papers). Maria Bjerke is often cited by papers focused on Alzheimer's disease research and treatments (42 papers), Dementia and Cognitive Impairment Research (41 papers) and Neurological Disease Mechanisms and Treatments (11 papers). Maria Bjerke collaborates with scholars based in Belgium, Sweden and United Kingdom. Maria Bjerke's co-authors include Henrik Zetterberg, Kaj Blennow, Ulf Andréasson, Erik Portelius, Anders Wallin, Sebastiaan Engelborghs, Bob Olsson, Annika Öhrfelt, Christoffer Rosén and Mikko Hölttä and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Neurology.

In The Last Decade

Maria Bjerke

77 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

2016 1.4k citations Ulf Andréasson, Erik Portelius et al. profile →

Peers

Countries citing papers authored by Maria Bjerke

Since Specialization

Citations

This map shows the geographic impact of Maria Bjerke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Bjerke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Bjerke more than expected).

Fields of papers citing papers by Maria Bjerke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Bjerke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Bjerke. The network helps show where Maria Bjerke may publish in the future.

Co-authorship network of co-authors of Maria Bjerke

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Bjerke. A scholar is included among the top collaborators of Maria Bjerke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Bjerke. Maria Bjerke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world brain volumetry in multiple sclerosis: importance of methodological consistency and clinical relevance of gray matter atrophy 2025 ·Frontiers in Neurology ·(unknown), (unknown), Maria Bjerke, Marie D’hooghe, Guy Nagels, (unknown), Diana M. Sima, Dirk Smeets, Jeroen Van Schependom, Mandy Melissa Jane Wittens, Sebastiaan Engelborghs, Miguel D’haeseleer	0
2	Towards validation in clinical routine: a comparative analysis of visual MTA ratings versus the automated ratio between inferior lateral ventricle and hippocampal volumes in Alzheimer’s disease diagnosis 2024 ·Neuroradiology ·Mandy Melissa Jane Wittens, (unknown), Diana M. Sima, Tim Vanderhasselt, (unknown), Erik Fransen, Dirk Smeets, Johan De Mey, Maria Bjerke, Sebastiaan Engelborghs	4
3	Neurofilament light chain: A possible fluid biomarker in the intrahippocampal kainic acid mouse model for chronic epilepsy? 2023 ·Epilepsia ·(unknown), (unknown), (unknown), Kurt Barbé, Maria Bjerke, Ann Van Eeckhaut, Ilse Smolders	7
4	Brain Volume Loss Can Occur at the Rate of Normal Aging in Patients with Multiple Sclerosis Who Are Free from Disease Activity 2022 ·Journal of Clinical Medicine ·(unknown), (unknown), Sebastiaan Engelborghs, Kaat Guldolf, Guy Nagels, Dirk Smeets, (unknown), Lars Costers, Marie D’hooghe, Anne‐Marie Vanbinst, Jeroen Van Schependom, Maria Bjerke, Miguel D’haeseleer	7
5	Higher susceptibility to 6 Hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of Alzheimer's disease 2022 ·Epilepsia ·(unknown), Melissa Barker‐Haliski, Najat Aourz, Guy Nagels, Maria Bjerke, Sebastiaan Engelborghs, Dimitri De Bundel, Ilse Smolders	17
6	Investigating Tissue-Specific Abnormalities in Alzheimer’s Disease with Multi-Shell Diffusion MRI 2022 ·Journal of Alzheimer s Disease ·(unknown), Robert E. Smith, Hanne Struyfs, Ellis Niemantsverdriet, Ellen De Roeck, Maria Bjerke, Sebastiaan Engelborghs, Eduardo Romero, Jan Sijbers, Ben Jeurissen	6
7	Shared CSF Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus and Subcortical Small Vessel Disease 2022 ·Frontiers in Neurology ·Anna Jeppsson, Maria Bjerke, Per Hellström, Kaj Blennow, Henrik Zetterberg, Petronella Kettunen, Carsten Wikkelsø, Anders Wallin, Mats Tullberg	16
8	Evaluation of four laboratory-based SARS-CoV-2 IgG antibody immunoassays 2021 ·Diagnostic Microbiology and Infectious Disease ·(unknown), (unknown), Denis Piérard, Ilse Weets, Maria Bjerke, Johan Schiettecatte, Deborah De Geyter	12
9	Hippocampal Sclerosis in Frontotemporal Dementia: When Vascular Pathology Meets Neurodegeneration 2021 ·Journal of Neuropathology & Experimental Neurology ·Anne Sieben, Tim Van Langenhove, Yannick Vermeiren, (unknown), Marleen Praet, Dimitri Vanhauwaert, (unknown), Sebastiaan Engelborghs, Robrecht Raedt, Paul Boon, Patrick Santens, Peter Paul De Deyn, Ken R. Bracke, (unknown), Christine Van Broeckhoven, Jean‐Jacques Martin, Maria Bjerke	7
10	A Novel Tau Antibody Detecting the First Amino-Terminal Insert Reveals Conformational Differences Among Tau Isoforms 2020 ·Frontiers in Molecular Biosciences ·(unknown), Nick Geukens, Sabiha Eddarkaoui, (unknown), (unknown), (unknown), Vanessa Franssens, (unknown), Cindy François, Erik Stoops, Maria Bjerke, Sebastiaan Engelborghs, (unknown), (unknown), Luc Buée, Eugeen Vanmechelen, Joris Winderickx, Debby Thomas	6
11	Validation of the Erlangen Score Algorithm for Differential Dementia Diagnosis in Autopsy-Confirmed Subjects 2019 ·Journal of Alzheimer s Disease ·Charisse Somers, Piotr Lewczuk, Anne Sieben, Christine Van Broeckhoven, Peter Paul De Deyn, Johannes Kornhuber, Jean‐Jacques Martin, Maria Bjerke, Sebastiaan Engelborghs	10
12	Subjective Cognitive Impairment Is a Predominantly Benign Condition in Memory Clinic Patients Followed for 6 Years: The Gothenburg-Oslo MCI Study 2017 ·Dementia and Geriatric Cognitive Disorders Extra ·Erik Hessen, Marie Eckerström, Arto Nordlund, Ina S. Almdahl, (unknown), Maria Bjerke, Carl Eckerström, Mattias Göthlin, Tormod Fladby, Ivar Reinvang, Anders Wallin	47
13	Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke 2017 ·BMC Neurology ·Ann De Vos, Maria Bjerke, Raf Brouns, Naomi De Roeck, Dirk Jacobs, (unknown), Kaat Guldolf, Henrik Zetterberg, Kaj Blennow, Sebastiaan Engelborghs, Eugeen Vanmechelen	68
14	No added diagnostic value of non-phosphorylated tau fraction (p-taurel) in CSF as a biomarker for differential dementia diagnosis 2017 ·Alzheimer s Research & Therapy ·(unknown), Maria Bjerke, Hanne Struyfs, Ellis Niemantsverdriet, Charisse Somers, Tobi Van den Bossche, Sara Van Mossevelde, Bart De Vil, Anne Sieben, Jean‐Jacques Martin, Patrick Cras, Johan Goeman, Peter Paul De Deyn, Christine Van Broeckhoven, Julie van der Zee, Sebastiaan Engelborghs	13
15	Alzheimer’s disease CSF biomarkers: clinical indications and rational use 2017 ·Acta Neurologica Belgica ·Ellis Niemantsverdriet, Sara Valckx, Maria Bjerke, Sebastiaan Engelborghs	85
16	CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment 2015 ·European Neuropsychopharmacology ·Sindre Rolstad, Joel Jakobsson, Carl M. Sellgren, Anniella Isgren, Carl Johan Ekman, Maria Bjerke, Kaj Blennow, Henrik Zetterberg, Erik Pålsson, Mikael Landén	44
17	Altered Cerebrospinal Fluid Levels of Amyloid β and Amyloid Precursor-Like Protein 1 Peptides in Down’s Syndrome 2014 ·NeuroMolecular Medicine ·Erik Portelius, Mikko Hölttä, Hilkka Soininen, Maria Bjerke, Henrik Zetterberg, (unknown), Sanna‐Kaisa Herukka, Kaj Blennow, Niklas Mattsson	25
18	Cerebrovascular Biomarker Profile Is Related to White Matter Disease and Ventricular Dilation in a LADIS Substudy 2014 ·Dementia and Geriatric Cognitive Disorders Extra ·Maria Bjerke, Michael Jonsson, Arto Nordlund, Carl Eckerström, Kaj Blennow, Henrik Zetterberg, Leonardo Pantoni, Domenico Inzitari, Reinhold Schmidt, Anders Wallin	26
19	Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease 2010 ·Brain Research ·Annika Thorsell, Maria Bjerke, Johan Gobom, (unknown), Eugeen Vanmechelen, Niels Andreasen, Oskar Hansson, Lennart Minthon, Henrik Zetterberg, Kaj Blennow	158
20	Subcortical Vascular Dementia Biomarker Pattern in Mild Cognitive Impairment 2009 ·Dementia and Geriatric Cognitive Disorders ·Maria Bjerke, Ulf Andréasson, Sindre Rolstad, Arto Nordlund, K. Lind, Henrik Zetterberg, Åke Edman, Kaj Blennow, Anders Wallin	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact